A review on Pharmacovigilance and drug safety post-marketing surveillance

Lokesh Gavatiya, Shweta Gogate*, Rita Mourya, Somesh Kumar Saxena, Bharti Patel

SAM College of Pharmacy, SAM Global University, Raisen, Madhya Pradesh, India

Refer this article

Lokesh Gavatiya, Shweta Gogate, Rita Mourya, Somesh Kumar Saxena, Bharti Patel, A review on Pharmacovigilance and drug safety post-marketing surveillance. March-April 2025, V3 – I2, Pages - 35 – 38. Doi: https://doi.org/10.55522/ijti.v3i2.0112

ABSTRACT

Drug students play an important role in ensuring drug safety by monitoring unwanted drug reactions (ADRs) and other drug problems once drugs enter the market. This review examines the importance of subsequent market surveillance (PMS) for the identification, evaluation and prevention of side effects that may not be recognized by side effects. Various pharmacy systems, regulatory framework conditions, and reporting mechanisms used around the world are being discussed, highlighting their impact on public health and drug safety. Issues related to reporting, data management and regulatory harmonization can also be examined. This check concludes with recommendations to improve drug students' practices to improve patient safety and optimize the effectiveness of the drug in a real environment.

Keywords:

Pharmacovigilance, Drug Safety, Post-Marketing Surveillance, Adverse Drug Reactions (ADRs), Risk Management, Regulatory Frameworks, Drug Monitoring, Public Health, Spontaneous Reporting, Signal Detection